Dr Sandra Appiah currently works at the Department of Natural Sciences, Middlesex University, UK.
She specialises in teaching metabolic and nutritional biochemistry. Her research focus is on the modulation of death and survival signaling pathways in cell models of leukaemia and Alzheimer’s disease by phytochemicals.
Hasan, Noor and Roberts, Helen and Ghali, Lucy and Appiah, Sandra S. (2018) The combination of curcumin and doxorubicin shows a selective cytotoxic effect on acute myeloid leukaemia cell line. In: NCRI Cancer Conference (2018), 04-06 Nov 2018, Glasgow, Scotland.
Vu, Milan and Kassouf, Nick and Bell, Celia M. and Appiah, Sandra S. (2018) Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio. In: NCRI Cancer Conference (2018), 04-06 Nov 2018, Glasgow, Scotland.
Onatade, Raliat and Appiah, Sandra S. and Stephens, Martin and Garelick, Hemda (2018) Evidence for the outcomes and impact of clinical pharmacy: context of UK hospital pharmacy practice. European Journal of Hospital Pharmacy , 25 (e1). e21-e28. ISSN 2047-9956
Wang, Scarlet Xiaoyan and Wen, Xuesong and Bell, Celia M. and Appiah, Sandra S. (2018) Liposome‑delivered baicalein induction of myeloid leukemia K562 cell death via reactive oxygen species generation. Molecular Medicine Reports , 17 (3). pp. 4524-4530. ISSN 1791-2997
Osemeke, Cynthia and Garelick, Hemda and Wen, Xuesong and Appiah, Sandra S. (2018) α-Mangostin, singly and in combination with Doxorubicin, as pro-apoptotic agents and protein kinase inhibitors In the AML cell line, Molm13. In: EACR Conference Series: A matter of Life or Death. from Basic cell Death Mechanism to Novel cancer Treatment, 1th-3rd Feb. 2018, Amstardam, Netherlands.